







 
 
  







<HTML>
<HEAD>
<TITLE>JBC --  Bonten and d'Azzo 275 (48): 37657</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>



	<!-- has inhead tag -->
	 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
	

<meta name="robots" content="nofollow">
</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A TARGET="_top" HREF="/cgi/adclick?journal=jbc&ad=ARC&url=http://www.arc-inc.com/&side=only"><IMG BORDER=2 WIDTH=220 HEIGHT=40 SRC="/ads/gifs/918056646.gif" ALT="American Radiolabeled Chemicals"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue48/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE="">
	<TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	




	


	
	
	
	 

	


	
	




				<BR><FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F275%2F48%2F37657">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	
<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>
	



         
                
        



	
		
		
	 
 




		<FONT COLOR="#A70716"></FONT>
	
	<FONT SIZE=-1>Originally published In Press as  <A HREF="/cgi/content/abstract/M007380200v1">doi:10.1074/jbc.M007380200</A> on September 11, 2000</FONT>


	
		
		<P><FONT SIZE=-1>J. Biol. Chem., Vol. 275, Issue 48, 37657-37663, December 1, 2000</FONT><BR>
		
	

 

 
	  
		                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/48/37657">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/48/37657">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/48/37657">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/48/37657&title=Lysosomal+Neuraminidase.+CATALYTIC+ACTIVATION+IN+INSECT+CELLS+IS+CONTROLLED+BY+THE+PROTECTIVE+PROTEIN%2FCATHEPSIN+A">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M007380200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10982818&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10982818&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		
		<TR><TD><FONT SIZE="-1">
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="#otherarticles">other online articles</A>
		</FONT></TD></TR>
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Bonten+EJ&link_type=AUTHORSEARCH">Bonten, E. J.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=d%27Azzo+A&link_type=AUTHORSEARCH">d'Azzo, A.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/48/37657&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F48%2F37657"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/48/37657">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/48/37657<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M007380200v1">M007380200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


	









 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">

<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->





<H2>
<FONT COLOR=A70716 SIZE=-1>

</FONT>

    Lysosomal Neuraminidase
    <BR>

<font size=-1><BR>CATALYTIC ACTIVATION IN INSECT CELLS IS CONTROLLED BY THE
PROTECTIVE  PROTEIN/CATHEPSIN A<A HREF="#FN150"><SUP>*</SUP></A></font>
</H2>



<STRONG>
<NOWRAP>
Erik J. 
Bonten and<WBR>
Alessandra 
d'Azzo<A HREF="#FN152"><SUP><IMG SRC="/math/12pt/normal/link/Dagger.gif" ALIGN=BASELINE ALT="Dagger" BORDER=0></SUP></A>
</NOWRAP>
</STRONG>
<P>
From St. Jude Children's Research Hospital, Department of
Genetics, Memphis, Tennessee 38105
<P>
Received for publication, August 14,&nbsp;2000, and in revised form, September 7,&nbsp;2000
<P>






    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    







<a name = "Abstract"><!-- comment for mosaic --></a>



<A NAME="Abstract"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>ABSTRACT</FONT>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

<P>Lysosomal <I>N</I>-Acetyl-<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-neuraminidase
is active in complex with the protective protein/cathepsin A (PPCA</A>) and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase.<SUP> </SUP>The interaction with PPCA</A> is essential for the
correct intracellular<SUP> </SUP>routing and lysosomal localization of
neuraminidase, but the mechanism<SUP> </SUP>of its catalytic activation is
unclear. To investigate this process,<SUP> </SUP>we have used the baculovirus
expression system to co-express neuraminidase<SUP> </SUP>and PPCA</A> precursors in
insect cells, which resulted in high enzymatic<SUP> </SUP>activity of
neuraminidase. Both the 34-&nbsp;and 20-kDa PPCA</A> subunits<SUP> </SUP>were required for
the activation. We further demonstrated that<SUP> </SUP>when expressed alone, the
neuraminidase precursor remained dimeric<SUP> </SUP>(114&nbsp;kDa) and had low
enzymatic activity, but when co-expressed<SUP> </SUP>with PPCA</A> and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, it multimerized in a complex of<SUP> </SUP>~1350 kDa,
together with the other two proteins. The fully active<SUP> </SUP>neuraminidase
co-precipitated with full-length PPCA</A> and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase<SUP> </SUP>precursors.
However, when co-expressed with the individual PPCA</A><SUP> </SUP>subunits,
neuraminidase co-precipitated only with the small 20-kDa<SUP> </SUP>polypeptide,
which therefore must contain a neuraminidase-binding<SUP> </SUP>site. Our finding
suggests a model of activation of neuraminidase<SUP> </SUP>dependent on its
oligomerization at acidic pH that is mediated<SUP> </SUP>by interaction with
PPCA</A>.
<BR><BR CLEAR=ALL>




<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>

    
    

    
    

    
    
	
	
	
<A NAME="Introduction"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;INTRODUCTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>INTRODUCTION</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

    

<P>Lysosomal neuraminidase (EC 3.2.1.18) catalyzes the intralysosomal
degradation of sialoglycoconjugates by releasing terminal<SUP> </SUP>sialic acid
from their oligosaccharide side chains. The human<SUP> </SUP>enzyme is involved in
two genetically distinct lysosomal storage<SUP> </SUP>disorders: sialidosis, which
is caused by mutations in the lysosomal<SUP> </SUP>neuraminidase gene (<A HREF="#B1">1</A>, <A HREF="#B2">2</A>), and
galactosialidosis, which<SUP> </SUP>is the combined deficiency of neuraminidase
and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase,<SUP> </SUP>caused by a primary deficiency of the protective
protein/cathepsin<SUP> </SUP>A (PPCA</A>)<SUP>1</SUP>
(<A HREF="#B3">3-5</A>).
</P>
<P>In mammalian tissues, neuraminidase is present in a high molecular
weight multienzyme complex with PPCA</A> and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase<SUP> </SUP>and
copurifies with these enzymes on affinity chromatography columns<SUP> </SUP>for
either <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase or PPCA</A> (<A HREF="#B6">6-12</A>). Pshezhetsky and Potier<SUP> </SUP>(<A HREF="#B6">6</A>)
have reported that <I>N</I>-acetylgalactosamine-6-sulfate sulfatase<SUP> </SUP>can also be present in the multienzyme complex, although confirmation<SUP> </SUP>of this finding or a follow-up has not yet been reported. Only<SUP> </SUP>a small
percentage of PPCA</A> and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase activities are<SUP> </SUP>consistently
measured in the multienzyme complex (1-2% of total),<SUP> </SUP>which instead
contains all of the neuraminidase activity. Apparently,<SUP> </SUP>PPCA</A> and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase are active also outside the complex,<SUP> </SUP>while
neuraminidase is not (<A HREF="#B6">6-15</A>). Verheijen <I>et al.</I> (<A HREF="#B8">8</A>) have<SUP> </SUP>shown that human neuraminidase purified from placenta was inactive<SUP> </SUP>at
neutral pH but could be reactivated <I>in vitro</I> by
concentrating<SUP> </SUP>the preparation at 37&nbsp;&#176;C and acidic pH, which resulted
in a 4-fold<SUP> </SUP>increase in activity for every 2-fold increase of
concentration.<SUP> </SUP>On sucrose density gradients, the "stabilized"
enzyme coprecipitated<SUP> </SUP>with the 32-kDa PPCA</A> subunit and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, suggesting that<SUP> </SUP>assembly into a multienzyme complex
stabilized/protected the neuraminidase<SUP> </SUP>activity. In galactosialidosis
fibroblasts, in the absence of<SUP> </SUP>PPCA</A>, the 10-15% residual
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase activity increased upon<SUP> </SUP>addition to the culture
medium of the protease inhibitor leupeptin,<SUP> </SUP>which pointed to a
protective role of PPCA</A> against proteolytic<SUP> </SUP>degradation of
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase (<A HREF="#B6">6</A>, <A HREF="#B16">16</A>, <A HREF="#B17">17</A>). In contrast,<SUP> </SUP>neuraminidase activity
remained undetectable after leupeptin treatment<SUP> </SUP>unless PPCA</A> was added
(<A HREF="#B6">6</A>, <A HREF="#B16">16</A>, <A HREF="#B17">17</A>), suggesting a different<SUP> </SUP>way for PPCA</A> to influence
neuraminidase<SUP> </SUP>activity.
</P>
<P>We have previously shown that human and mouse lysosomal neuraminidase
expressed in COS-1 cells and fibroblasts from patients<SUP> </SUP>with sialidosis
associate with PPCA</A> shortly after synthesis and<SUP> </SUP>segregate to mature
lysosomes only when accompanied by wild-type<SUP> </SUP>PPCA</A>, but not by
transport-impaired PPCA</A> mutants (<A HREF="#B18">18</A>). Early<SUP> </SUP>interaction is needed
because neuraminidase is poorly phosphorylated,<SUP> </SUP>even in the presence of
PPCA</A>, and its mannose 6-phosphate marker<SUP> </SUP>is not functional in
receptor-mediated endocytosis of the enzyme<SUP> </SUP>(<A HREF="#B18">18</A>). Thus, PPCA</A> functions
as an auxiliary transport protein<SUP> </SUP>for neuraminidase, and neuraminidase
acquires full enzymatic activity<SUP> </SUP>in mature lysosomes only when bound to
PPCA</A>. In contrast, others<SUP> </SUP>have reported that in galactosialidosis
fibroblasts, neuraminidase<SUP> </SUP>does reach the lysosomes but is rapidly
degraded because of the<SUP> </SUP>absence of functional PPCA</A> (<A HREF="#B19">19</A>). Thus, the
exact mechanism by<SUP> </SUP>which PPCA</A> controls both the catalytic activation of
neuraminidase<SUP> </SUP>and the maintenance/regulation of its enzymatic activity
is<SUP> </SUP>unknown.
</P>
<P>We have utilized the baculovirus (BV</A>) expression in insect cells to
study the mechanism of catalytic activation of PPCA</A> and<SUP> </SUP>demonstrated
that the one-chain zymogen is cleaved into a two-chain<SUP> </SUP>mature enzyme by
a trypsin-like protease, removing a linker peptide<SUP> </SUP>between the two
subunits (<A HREF="#B20">20</A>). The structural basis of this<SUP> </SUP>activation mechanism were
assessed after the determination of<SUP> </SUP>the three-dimensional structure of
human PPCA</A> precursor that showed<SUP> </SUP>that the active site is preformed in
the zymogen but is blocked<SUP> </SUP>by a "maturation subdomain" (<A HREF="#B21">21</A>).
Removal of the linker peptide<SUP> </SUP>causes conformational changes of the
maturation subdomain, exposing<SUP> </SUP>the active site (<A HREF="#B21">21</A>).
</P>
<P>Here we have developed a similar approach to elucidate the mechanism of
catalytic activation of neuraminidase in insect cells.<SUP> </SUP>When using
baculovirus constructs, several factors can influence<SUP> </SUP>the level of
protein expression in insect cells, including the<SUP> </SUP>type of baculovirus
vector, the type of insect cells, the multiplicity<SUP> </SUP>of infection, the
type of culture medium, the time of infection,<SUP> </SUP>and the stability of the
overexpressed protein (<A HREF="#B22">22</A>, <A HREF="#B23">23</A>). When<SUP> </SUP>high expression levels are
achieved, the recombinant protein is<SUP> </SUP>usually clearly visible on
Coomassie-stained SDS-gels containing<SUP> </SUP>total cell lysates. Taking that
into account, we expressed neuraminidase<SUP> </SUP>in insect cells and studied
the <I>in vivo</I> and <I>in vitro</I> interactions<SUP> </SUP>with
co-expressed PPCA</A> and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase. Our results indicate<SUP> </SUP>that
neuraminidase is catalytically activated by conformational<SUP> </SUP>changes that
occur when the enzyme shifts from a 114-kDa dimeric<SUP> </SUP>form to an
oligomeric complex of ~1350 kDa. This activation occurs<SUP> </SUP>exclusively
at acidic pH and is triggered by its interaction with<SUP> </SUP>PPCA</A>.
<BR><BR CLEAR=ALL>



<A NAME="SEC1"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXPERIMENTAL PROCEDURES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXPERIMENTAL PROCEDURES</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Cell Culture and Generation of Recombinant Baculovirus
Constructs--</I>

<I>Spodoptera frugiperda</I> insect cells
(IPLB-SF21) were cultured in monolayers at 27&nbsp;&#176;C in TNM-FH medium
(<A HREF="#B24">24</A>), supplemented<SUP> </SUP>with 10% fetal bovine serum and antibiotics.
Recombinant BV</A> constructs<SUP> </SUP>encoding mouse and human neuraminidase
(Moneur and Huneur, respectively),<SUP> </SUP>human <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, and mouse
PPCA</A> (MPP54) were generated through<SUP> </SUP>homologous recombination in insect
cells of wild-type BV</A> DNA (AcMNPV)<SUP> </SUP>and the respective cDNAs (<A HREF="#B20">20</A>,
<A HREF="#B25">25</A>, <A HREF="#B26">26</A>), which were subcloned<SUP> </SUP>into the BV</A> transfer plasmids
pJR<SUB>2</SUB> and pBC<SUB>3</SUB> (<A HREF="#B20">20</A>, <A HREF="#B27">27</A>). The<SUP> </SUP>generation and
characterization of BV</A> constructs encoding human<SUP> </SUP>PPCA</A> (HPP54) and the
two separate human PPCA</A> subunits (PP32 and<SUP> </SUP>PP20) was described earlier
(<A HREF="#B20">20</A>).



    

    


<P><I>Development of Antibodies--</I>

Polyclonal antibodies were raised
in rabbits (Rockland) against BV-expressed human <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase,
human PPCA</A> (anti-hPPCA),<SUP> </SUP>and mouse PPCA</A> (anti-mPPCA) precursor
proteins. The secreted proteins<SUP> </SUP>were affinity-purified on concanavalin
A-Sepharose (Amersham Pharmacia<SUP> </SUP>Biotech). The generation of anti-human
neuraminidase antibodies<SUP> </SUP>(anti-Neur) was described earlier (<A HREF="#B2">2</A>). All
antibodies recognize<SUP> </SUP>the BV-expressed proteins against which they were
raised but also<SUP> </SUP>the endogenous mammalian<SUP> </SUP>proteins.



    

    


<P><I>Metabolic Labeling of Infected Insect Cells--</I>

For
biosynthetic labeling studies, Sf21 cells were seeded in
six-well dishes and grown until 80-90% confluence and infected<SUP> </SUP>with
BV</A> at a multiplicity of infection of 5&nbsp;plaque-forming units/cell.<SUP> </SUP>Two
days after infection, the cells were radiolabeled for 16&nbsp;h<SUP> </SUP>with 50&nbsp;&#181;Ci/ml [<SUP>35</SUP>S]methionine. Immunoprecipitations were
carried out as described<SUP> </SUP>earlier (<A HREF="#B20">20</A>, <A HREF="#B28">28</A>, <A HREF="#B29">29</A>). Immunoprecipitated
proteins were resolved<SUP> </SUP>on 12.5% SDS-PAGE and visualized by
fluorography of the gels soaked<SUP> </SUP>in Amplify (Amersham Pharmacia<SUP> </SUP>Biotech).



    

    


<P><I>Purification of Neuraminidase--</I>

Sf21 cells were
propagated in three-dimensional bottles (Nunc) until 80-90%
confluence and infected at a multiplicity of infection<SUP> </SUP>of 5&nbsp;with
Moneur. The cells were dislodged 2&nbsp;days after infection<SUP> </SUP>by tapping the
bottles firmly. All steps were carried out at 4<SUP> </SUP>&#176;C unless indicated
otherwise. The cells were washed in phosphate-buffered<SUP> </SUP>saline and
pelleted by centrifugation at 1000&nbsp;rpm. The cells were<SUP> </SUP>lysed in water
and 1% Nonidet P-40 (Calbiochem) for 30&nbsp;min. Triethanolamine<SUP> </SUP>(TEA</A>; stock solution: 0.2&nbsp;<font size=-1>M</font>, pH 8.75) and water were added
to<SUP> </SUP>the lysate to obtain final concentrations: 20&nbsp;m<font size=-1>M</font> TEA</A>, pH
8.75,<SUP>&nbsp;</SUP>0.1% Nonidet P-40. The lysate was ultracentrifugated (Beckman<SUP> </SUP>SW28 rotor, 25,000&nbsp;rpm, 1&nbsp;h), and the supernatant was filtered<SUP> </SUP>through a 0.2-&#181;m filter. Neuraminidase was fast protein liquid<SUP> </SUP>chromatography-purified on a Resource Q column (Amersham Pharmacia<SUP> </SUP>Biotech) and eluted with a salt gradient of 0-150 m<font size=-1>M</font> NaCl
(20<SUP>&nbsp;</SUP>m<font size=-1>M</font> TEA</A>, pH 8.75). The neuraminidase eluted at ~80
m<font size=-1>M</font> NaCl and<SUP> </SUP>was concentrated in Centriprep 10&nbsp;units
(Amicon) to 1-3 mg/ml.<SUP> </SUP>Neuraminidase was further purified on a
Sephacryl S300HR column<SUP> </SUP>(Amersham Pharmacia Biotech) in 20&nbsp;m<font size=-1>M</font> TEA</A>, pH 8.75,&nbsp;100&nbsp;m<font size=-1>M</font> NaCl.<SUP> </SUP>The
neuraminidase-containing fractions were pooled and concentrated<SUP> </SUP>as
described above. The column was calibrated with molecular weight<SUP> </SUP>markers (Amersham Pharmacia<SUP> </SUP>Biotech).



    

    


<P><I>In Vitro Activation of Neuraminidase--</I>

Fixed amounts of
purified mouse neuraminidase were mixed with increasing concentrations
of concanavalin A-Sepharose-purified<SUP> </SUP>mouse PPCA</A>, human PPCA</A>, human
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, or bovine serum<SUP> </SUP>albumin in 50&nbsp;m<font size=-1>M</font> sodium
acetate, pH 5.0&nbsp;or 6.8,&nbsp;and 100&nbsp;m<font size=-1>M</font> NaCl<SUP> </SUP>and incubated at
room temperature for 1&nbsp;h. Neuraminidase activity<SUP> </SUP>was assayed with
the artificial 4-methylumbelliferyl substrate<SUP> </SUP>(Sigma) according to
Galjaard (<A HREF="#B43">43</A>). Aliquots of <I>in vitro</I> activated<SUP> </SUP>neuraminidase with and without PPCA</A> were resolved on a Sephacryl<SUP> </SUP>S300HR
column (50&nbsp;m<font size=-1>M</font> sodium acetate, pH 5.0,&nbsp;100&nbsp;m<font size=-1>M</font>
NaCl). Eluted<SUP> </SUP>fractions were separated on 12.5% SDS-PAGE, blotted on
polyvinylidene<SUP> </SUP>difluoride membranes (Immobilon; Millipore Corp.), and
incubated<SUP> </SUP>with anti-Neur and anti-PPCA<SUP> </SUP>antibodies.



    

    


<P><I>In Vivo Activation of Neuraminidase and Gel
Filtration--</I>

Sf21 cells were infected in six-well dishes
with fixed amounts of Moneur and increasing amounts of either MPP54,
HPP54, PP32,<SUP> </SUP>PP20, and PP20 plus PP32 (as described above). Two days
after<SUP> </SUP>infection, the cells were harvested, and the neuraminidase
activity<SUP> </SUP>was assayed. The cell lysates were separated on a Sephacryl
S300HR<SUP> </SUP>gel filtration column (50&nbsp;m<font size=-1>M</font> sodium phosphate, pH
7.0,&nbsp;100&nbsp;m<font size=-1>M</font><SUP> </SUP>NaCl), and the eluates were analyzed by
SDS-PAGE/Western blotting<SUP> </SUP>and neuraminidase activity assays (as
described<SUP> </SUP>above).



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC2"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RESULTS</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RESULTS</FONT>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Baculovirus Expression in Insect Cells of Neuraminidase, PPCA</A>, and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-Galactosidase and in Vivo Catalytic Activation of
Neuraminidase--</I>

In mammalian cells, neuraminidase depends on its
association with a transport-competent PPCA</A> for lysosomal localization
(<A HREF="#B18">18</A>).<SUP> </SUP>In insect cells, instead, PPCA</A> does not reach the vacuole but<SUP> </SUP>accumulates in the endoplasmic reticulum and Golgi compartments<SUP> </SUP>and is
hardly processed into the mature and catalytically active<SUP> </SUP>two-chain
form (<A HREF="#B20">20</A>). Using BV-infected insect cells to co-express<SUP> </SUP>neuraminidase
with PPCA</A> and/or <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, we could now test<SUP> </SUP>whether PPCA</A>
influences neuraminidase activity in a manner that<SUP> </SUP>is independent from
its intracellular compartmentalization. For<SUP> </SUP>co-expression studies, it
was crucial to obtain comparable levels<SUP> </SUP>of expression of the different
components. Previously we overexpressed<SUP> </SUP>in Sf21 cells three
baculovirus constructs that encode the human<SUP> </SUP>PPCA</A> (HPP54) and the two
separate PPCA</A> subunits (PP32 and PP20)<SUP> </SUP>(<A HREF="#B20">20</A>). The expression levels of
these proteins were comparable<SUP> </SUP>as demonstrated by immunoprecipitation,
Western blotting, and<SUP> </SUP>Coomassie staining of SDS-gels (<A HREF="#B20">20</A>). We now made
baculovirus<SUP> </SUP>constructs that encode human neuraminidase (Huneur), mouse
neuraminidase<SUP> </SUP>(Moneur), mouse PPCA</A> (MPP54), and human
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase. To select<SUP> </SUP>the best expressing clones, up to 10&nbsp;baculovirus clones were screened<SUP> </SUP>for each protein by infecting the
virus in Sf21 cells and analyzing<SUP> </SUP>the recombinant proteins on
Coomassie-stained SDS-gels, before<SUP> </SUP>and after concanavalin A-Sepharose
purification (see "Experimental<SUP> </SUP>Procedures"). Furthermore, the best
expressing clones were also<SUP> </SUP>tested in metabolically labeled insect
cells infected individually<SUP> </SUP>with 50&nbsp;&#181;l of Moneur-, MPP54-, HPP54-,
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase-, HPP34-,<SUP> </SUP>and HPP20-recombinant baculoviruses. Two
days after infection,<SUP> </SUP>cells were labeled for 16&nbsp;h with
[<SUP>35</SUP>S]methionine. Radiolabeled proteins were
immunoprecipitated with<SUP> </SUP>specific antibodies (anti-Neur, anti-PPCA, and
anti-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase)<SUP> </SUP>and subjected to SDS-PAGE (Fig.
<a href="#F1">1</a><I>A</I>). The molecular weights of<SUP> </SUP>the expressed and immunoprecipitated proteins are summarized in<SUP> </SUP>Table
<a href="#TI">I</a>. The 18-&nbsp;and 75-kDa polypeptides (Fig.
<a href="#F1">1</a><I>A</I>, <I>lanes 5</I>&nbsp;and<SUP> </SUP><I>8</I>)
represented nonglycosylated forms of the small PPCA</A> subunit<SUP> </SUP>and the
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase precursor, respectively, since treatment<SUP> </SUP>with
<I>N</I>-glycosidase F or inhibition with the <I>N</I>-linked
glycosylation<SUP> </SUP>inhibitor tunicamycin did not alter their mobility on
SDS-PAGE<SUP> </SUP>(Ref. <A HREF="#B20">20</A>; data not shown). These results confirmed that all<SUP> </SUP>proteins were expressed at similar levels, with the exception<SUP> </SUP>of human
neuraminidase (Huneur), which was expressed at a considerably<SUP> </SUP>lower
level than the other proteins (Fig. <a href="#F1">1</a><I>A</I>, <I>lane
2</I>). For this<SUP> </SUP>reason, we chose to use the mouse (Moneur)
rather than the human<SUP> </SUP>neuraminidase construct (Huneur) in co-expression
experiments.<SUP> </SUP>This approach was further justified by earlier studies
demonstrating<SUP> </SUP>that interaction of the three enzymes is not
species-specific,<SUP> </SUP>but each of the human enzymes can be substituted by
its murine<SUP> </SUP>counterpart in the enzyme-complex (<A HREF="#B26">26</A>, <A HREF="#B30">30</A>, <A HREF="#B31">31</A>).



<BR CLEAR=ALL><A NAME="F1"><!-- FIG 1 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/48/37657/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=99 HEIGHT=200 SRC="/content/vol275/issue48/images/small/bc4609180001.gif"></A><BR>

<STRONG>View larger version</STRONG> (29K):
<BR><NOBR><A HREF="/cgi/content/full/275/48/37657/F1">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/48/37657/F1"
onClick="startTarget('F1', 367, 640); this.href='/cgi/content-nw/full/275/48/37657/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. &nbsp;</STRONG>

<B>Baculovirus expression in insect cells of
neuraminidase, </B><B>PPCA</B></A><B>, and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase and
<I>in vivo</I> activation of neuraminidase.</B>
<I>A</I>, Sf21 cells were singly infected with Moneur,
Huneur, PP32, PP20, HPP54, MPP54, and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase. Newly
synthesized proteins were radiolabeled with
[<SUP>35</SUP>S]methionine, 2&nbsp;days after infection, followed by
immunoprecipitation with either ant-Neur, anti-PPCA, or
anti-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase (<I>anti-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">gal</I>) antibodies.
Proteins were separated on SDS-PAGE and visualized by fluorography
(exposure time 5&nbsp;h). <I>B</I>, Sf21 cells were
co-infected with a constant amount (50&nbsp;&#181;l) of mouse neuraminidase
inoculum (Moneur) and increasing concentrations of either mouse PPCA</A>
precursor (MPP54), human PPCA</A> precursor (HPP54), or human
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase precursor (50,&nbsp;100,&nbsp;200,&nbsp;and 300&nbsp;&#181;l). Two days
after infection, the cells were harvested and assayed for neuraminidase
activity (nmol/h/ml). The activities are an average of three
experiments. Cell lysates were analyzed for expression of neuraminidase
on Western blots, incubated with anti-Neur antibodies
(<I>inset</I>). <I>C</I>, insect cells were co-infected with a
constant amount (50&nbsp;&#181;l) of Moneur and increasing amounts of
the two human PPCA</A> subunits (PP20 and PP34) or the combination of both
(0,&nbsp;50,&nbsp;100,&nbsp;200,&nbsp;and 300&nbsp;&#181;l). Two days after infection, the cells
were harvested and assayed for neuraminidase activity (nmol/h/ml). The
activities are an average of three experiments. The cell lysates were
analyzed for expression of neuraminidase on Western blots incubated
with anti-Neur antibodies (<I>inset</I>).


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->





<P><CENTER>
<TABLE BORDER WIDTH="95%" CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1><TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF><NOBR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</NOBR><BR><NOBR><STRONG>View this table:</STRONG></NOBR>
<BR><NOBR><A HREF="/cgi/content/full/275/48/37657/TI">[in this window]</A></NOBR><BR>
<NOBR><A HREF="/cgi/content-nw/full/275/48/37657/TI"
	onClick="startTarget('TI', 500, 400); this.href='/cgi/content-nw/full/275/48/37657/TI'"
	onMouseOver="window.status='View table in a separate window';
		return true"
TARGET='TI'>[in a new window]</A><BR>&nbsp;</NOBR>
</TD>
<TD ALIGN=LEFT VALIGN=TOP>
<A NAME="TI"><!-- TABLE I --></A>
<CENTER>
<B>Table I</B><BR>
<STRONG>

    Summary of immunoprecipitations
<BR>
</STRONG>
</CENTER>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>



<P>
Insect cells were co-infected with a constant amount of Moneur (50&nbsp;&#181;l) and increasing virus concentrations of either MPP54,<SUP> </SUP>HPP54, or
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase (50-300 &#181;l). The cells were harvested<SUP> </SUP>2&nbsp;days after
infection and assayed for neuraminidase activity.<SUP> </SUP>Both human and mouse
PPCA</A> were able to increase the neuraminidase<SUP> </SUP>activity in a
concentration-dependent manner, although mouse PPCA</A><SUP> </SUP>was
somewhat more effective in this function (Fig. <a href="#F1">1</a><I>B</I>), whereas<SUP> </SUP><IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase had no effect at all on the neuraminidase activity<SUP> </SUP>(Fig. <a href="#F1">1</a><I>B</I>). Aliquots of the different cell lysates, analyzed
on<SUP> </SUP>Western blots probed with anti-Neur antibodies, showed that the<SUP> </SUP>expression levels of the 46-kDa neuraminidase proteins were comparable<SUP> </SUP>in all samples. Small variations in expression levels and stability<SUP> </SUP>of
the human and mouse PPCA</A> may account for the differences in<SUP> </SUP>the level
of measured neuraminidase activity. Both human and mouse<SUP> </SUP>PPCA</A> did not
affect the level of expression or the stability of<SUP> </SUP>neuraminidase, as
shown on Western blots (Fig. <a href="#F1">1</a><I>B</I>, <I>inset</I>), but<SUP> </SUP>their interaction with neuraminidase clearly activated the<SUP> </SUP>enzyme.
<P>
To determine whether a full-length PPCA</A> was needed for this process or
either of the two PPCA</A> subunits (PP20 and PP32) would<SUP> </SUP>be sufficient for
neuraminidase activation, insect cells were<SUP> </SUP>co-infected with a constant
amount of Moneur inoculum (50&nbsp;&#181;l)<SUP> </SUP>and increasing concentrations of
PP20, PP32, or a combination<SUP> </SUP>of the two. Two days after infection,
cells were harvested and<SUP> </SUP>assayed for neuraminidase activity. The
separate subunits did<SUP> </SUP>not affect the enzyme activity (Fig.
<a href="#F1">1</a><I>C</I>). However, a significant<SUP> </SUP>increase in activity was
observed when both PPCA</A> subunits were<SUP> </SUP>co-expressed with neuraminidase
(Fig. <a href="#F1">1</a><I>C</I>). The levels of the 46-kDa<SUP> </SUP>protein on Western blots
were comparable in all samples (Fig.<SUP> </SUP><a href="#F1">1</a><I>C</I>, <I>inset</I>).
Thus, a full-length PPCA</A> protein, in the form of the<SUP> </SUP>one-chain
precursor or the two-chain mature enzyme, is needed<SUP> </SUP>for catalytic
activation of<SUP> </SUP>neuraminidase.



    

    


<P><I>Complex Formation of Neuraminidase with PPCA</A> and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-Galactosidase--</I>

Our results have shown that PPCA</A> by itself has
the ability to activate neuraminidase. We further investigated whether
the<SUP> </SUP>three-enzyme complex could assemble also in insect cells and
whether<SUP> </SUP>neuraminidase activity would change in the context of this
complex.<SUP> </SUP>We first analyzed by gel filtration the native molecular mass<SUP> </SUP>of mouse neuraminidase alone or in combination with the 85-kDa<SUP> </SUP><IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase precursor, the 54-kDa PPCA</A> precursor, or both<SUP> </SUP>PPCA</A>
subunits. Total cell lysates from BV-infected insect cells<SUP> </SUP>were
resolved on a Sephacryl S300HR column, and the eluted fractions<SUP> </SUP>were
analyzed on Western blots, probed with polyclonal antibodies<SUP> </SUP>specific
for either of the three proteins (see "Experimental
Procedures").<SUP> </SUP>Neuraminidase expressed alone eluted at a
molecular mass of ~114<SUP> </SUP>kDa, probably as a dimer (Fig.
<a href="#F2">2</a><I>A</I>). When co-expressed with
PPCA</A><SUP> </SUP>and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, a small amount of neuraminidase
oligomerized<SUP> </SUP>and eluted from the column in fractions corresponding to a
molecular<SUP> </SUP>mass of ~1350 kDa (Fig. <a href="#F2">2</a><I>B</I>). These fractions
also contained small<SUP> </SUP>amounts of PPCA</A> and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, suggesting
that the three<SUP> </SUP>enzymes were in complex (Fig. <a href="#F2">2</a><I>B</I>). However,
most of the neuraminidase,<SUP> </SUP>PPCA</A>, and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase eluted at
114-85 kDa (Fig. <a href="#F2">2</a><I>B</I>) and were<SUP> </SUP>not associated. When
co-expressed with both PPCA</A> subunits, a small<SUP> </SUP>percentage of
neuraminidase again eluted at ~1350 kDa (Fig. <a href="#F2">2</a><I>C</I>).<SUP> </SUP>However, neither of the two subunits was resolved together with<SUP> </SUP>neuraminidase in these fractions, suggesting that they were either<SUP> </SUP>only
transiently associated with neuraminidase, but just enough<SUP> </SUP>to trigger
the oligomerization of the enzyme, or they were still<SUP> </SUP>in complex with
neuraminidase, but their amount was too low to<SUP> </SUP>be detected on the
Western blot. Co-expression of neuraminidase<SUP> </SUP>with only
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase did not promote oligomerization of the<SUP> </SUP>enzyme (Fig.
<a href="#F2">2</a><I>D</I>), confirming that <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase was not directly<SUP> </SUP>involved in this process.



<BR CLEAR=ALL><A NAME="F2"><!-- FIG 2 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/48/37657/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=158 HEIGHT=200 SRC="/content/vol275/issue48/images/small/bc4609180002.gif"></A><BR>

<STRONG>View larger version</STRONG> (56K):
<BR><NOBR><A HREF="/cgi/content/full/275/48/37657/F2">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/48/37657/F2"
onClick="startTarget('F2', 497, 640); this.href='/cgi/content-nw/full/275/48/37657/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. &nbsp;</STRONG>

<B>Gel filtration of BV-expressed
neuraminidase.</B> Insect cells were either singly infected with
Moneur (<I>A</I>) or co-infected with Moneur, HPP54, and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">&nbsp;-galactosidase (<I><IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">gal</I>) (<I>B</I>); Moneur,
PP32, and PP20 (<I>C</I>); or Moneur and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase
(<I>D</I>). Two days after infection, the cells were harvested, and
the lysates were loaded on a Sephacryl S300HR gel filtration column
(Amersham Pharmacia Biotech). Eluted fractions (90-210 ml) were
subjected to SDS-PAGE, blotted on polyvinylidene difluoride membranes,
and probed with antibodies (indicated at the <I>right</I>). The gel
filtration column was precalibrated with molecular weight standards
(Amersham Pharmacia Biotech). Molecular weights of the eluted proteins
(native) and molecular weight standards are indicated at the
<I>top</I>. Molecular weights of the proteins after SDS-PAGE
(denatured) are indicated at the <I>left</I>. Elution volume is
indicated at the <I>bottom. E</I>, all gel filtration
fractions were assayed for neuraminidase activity (nmol/h/ml).


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->




<P>
The gel filtration eluates were also assayed for neuraminidase activity
(Fig. <a href="#F2">2</a><I>E</I>). The dimeric enzyme had very low activity<SUP> </SUP>(Fig.
<a href="#F2">2</a><I>E</I>, <I>upper left panel</I>). The
neuraminidase that was eluted<SUP> </SUP>at 1350&nbsp;kDa, together with PPCA</A> and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, was also<SUP> </SUP>catalytically active (Fig. <a href="#F2">2</a><I>E</I>,
<I>upper right panel</I>). Given that<SUP> </SUP>only a small
percentage of neuraminidase was resolved in these<SUP> </SUP>high molecular weight
fractions (Fig. <a href="#F2">2</a><I>B</I>, <I>lower panel</I>), this
oligomeric<SUP> </SUP>neuraminidase had a substantially higher specific activity
(10-20<SUP> </SUP>times) than the dimeric form. In contrast, the ~1350-kDa
oligomeric<SUP> </SUP>neuraminidase, resolved on gel filtration after
co-expression<SUP> </SUP>with the separate PPCA</A> subunits, was catalytically
inactive (Fig.<SUP> </SUP><a href="#F2">2</a><I>E</I>, <I>lower left
panel</I>), despite the relatively high amounts detected<SUP> </SUP>on
Western blots (Fig. <a href="#F2">2</a><I>C</I>). Thus, the oligomerization of
neuraminidase<SUP> </SUP>is not sufficient for its catalytic activation, which
apparently<SUP> </SUP>requires stable association with PPCA</A>.



    

    


<P><I>Co-precipitation of BV-expressed Neuraminidase with PPCA</A> and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-Galactosidase--</I>

To demonstrate that neuraminidase was indeed
associated with PPCA</A> and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, insect cells were
co-infected with<SUP> </SUP>the BV</A> constructs listed in Table <a href="#TI">I</a>. Two days after
infection,<SUP> </SUP>cells were metabolically labeled for 16&nbsp;h with
[<SUP>35</SUP>S]methionine. The radiolabeled proteins were
precipitated with<SUP> </SUP>specific antibodies (anti-Neur, anti-PPCA, anti-PP32,
anti-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase),<SUP> </SUP>and the immunoprecipitated products were
subjected to SDS-PAGE.<SUP> </SUP>The 54-kDa PPCA</A> precursor was readily
co-immunoprecipitated with<SUP> </SUP>neuraminidase using anti-Neur antibodies
(Fig. <a href="#F3">3</a>, <I>lane 2</I>).
Surprisingly,<SUP> </SUP>only the 20-kDa and not the 34-kDa subunit of PPCA</A>
co-precipitated<SUP> </SUP>with neuraminidase (Fig. <a href="#F3">3</a>, <I>lanes
3</I>&nbsp;and <I>4</I>), suggesting that this<SUP> </SUP>subunit contains a
neuraminidase-interacting domain. It is not<SUP> </SUP>clear at this moment
whether the large PPCA</A> subunit did not bind<SUP> </SUP>at all to neuraminidase or
whether this interaction was too weak<SUP> </SUP>to withstand the
immunoprecipitation conditions. The 34-kDa PPCA</A><SUP> </SUP>subunit was, however,
co-precipitated with the 20-kDa PPCA</A> polypeptide<SUP> </SUP>using antibodies that
are specific for the small subunit (Fig.<SUP> </SUP><a href="#F3">3</a>, <I>lane
6</I>). Neuraminidase also co-precipitated efficiently with<SUP> </SUP>the
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase precursor using anti-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase antibodies<SUP> </SUP>(Fig. <a href="#F3">3</a>, <I>lane 1</I>), indicating that the two
proteins did interact<SUP> </SUP>strongly, although <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase did not
appear to influence<SUP> </SUP>the activity of neuraminidase (Figs. <a href="#F1">1</a> and <a href="#F2">2</a>).
Mouse neuraminidase<SUP> </SUP>associated equally well with the human and mouse
forms of PPCA</A><SUP> </SUP>and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase (<A HREF="#B31">31</A>) (data not shown). As shown in
Fig.<SUP> </SUP><a href="#F3">3</a> (<I>lane 2</I>), PPCA</A> precursor co-precipitated
with neuraminidase<SUP> </SUP>only with anti-Neur and not with anti-PPCA
antibodies, while neuraminidase<SUP> </SUP>co-precipitated with <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase
only with anti-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase<SUP> </SUP>and not with anti-Neur antibodies
(Fig. <a href="#F3">3</a>, <I>lane 1</I>). This was probably<SUP> </SUP>caused by the
inability of some of the antibodies to recognize<SUP> </SUP>the associated
proteins, which may no longer expose the epitopes<SUP> </SUP>against which the
antibodies were raised. Together, the results<SUP> </SUP>indicate that
neuraminidase, PPCA</A>, and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase can physically<SUP> </SUP>associate in
insect cells, forming a ~1350-kDa enzyme-complex<SUP> </SUP>(Fig.
<a href="#F2">2</a><I>B</I>).



<BR CLEAR=ALL><A NAME="F3"><!-- FIG 3 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/48/37657/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=158 HEIGHT=200 SRC="/content/vol275/issue48/images/small/bc4609180003.gif"></A><BR>

<STRONG>View larger version</STRONG> (55K):
<BR><NOBR><A HREF="/cgi/content/full/275/48/37657/F3">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/48/37657/F3"
onClick="startTarget('F3', 498, 640); this.href='/cgi/content-nw/full/275/48/37657/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. &nbsp;</STRONG>

<B>Metabolic labeling and co-precipitation of
BV-expressed neuraminidase, </B><B>PPCA</B></A><B>,
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase
(<I><IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "></I><I>gal</I>), and the two separate </B><B>PPCA</B></A><B>
subunits.</B> Sf21 cells were co-infected with Moneur and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, MPP54, PP32, PP20, and PP32/PP20. Newly synthesized
proteins were radiolabeled with [<SUP>35</SUP>S]methionine 2&nbsp;days
after infection, followed by immunoprecipitation with either ant-Neur,
anti-PPCA, anti-PP32, or anti-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase antibodies. Proteins
were separated on SDS-PAGE and visualized by fluorography (exposure
time 5&nbsp;h). Co-precipitated polypeptides are indicated with
<I>white asterisks</I>.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->







    

    


<P><I>In Vitro Catalytic Activation of Neuraminidase--</I>

The ability to
produce in insect cells and purify large quantities of neuraminidase,
PPCA</A>, and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase (see "Experimental<SUP> </SUP>Procedures") allowed
us to test <I>in vitro</I> the catalytic activation<SUP> </SUP>of
neuraminidase. Dimeric mouse neuraminidase (pH 8.75) was mixed<SUP> </SUP>with
increasing amounts of either mouse or human PPCA</A> and incubated<SUP> </SUP>for
1&nbsp;h at room temperature at pH 5.0&nbsp;or 6.8.&nbsp;Afterward, the samples<SUP> </SUP>were assayed for neuraminidase activity. Incubation with both<SUP> </SUP>mouse and
human PPCA</A> (MPP54 and HPP54) resulted in the increase<SUP> </SUP>of neuraminidase
activity, but only under acidic conditions (Fig.<SUP> </SUP><a href="#F4">4</a><I>A</I>), while <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase
or bovine serum albumin had no effect<SUP> </SUP>on the activity (data not shown).
This demonstrated that PPCA</A><SUP> </SUP>controls the catalytic activation of
neuraminidase in a pH-dependent<SUP> </SUP>manner. To determine
whether catalytic activation had any effect<SUP> </SUP>on the molecular weight of
neuraminidase, we separated neuraminidase,<SUP> </SUP>either PPCA-activated or
mock-activated, on a Sephacryl S300HR<SUP> </SUP>gel filtration column. The
eluates were analyzed on Western blots<SUP> </SUP>probed with anti-Neur antibodies
(Fig. <a href="#F4">4</a><I>B</I>). PPCA-activated neuraminidase<SUP> </SUP>was recovered in two
separate pools, as oligomers of ~560 kDa<SUP> </SUP>and as oligomers of ~1100
kDa. In contrast, mock-incubated neuraminidase<SUP> </SUP>was mainly recovered in
fractions ranging from 100&nbsp;to 400&nbsp;kDa<SUP> </SUP>(Fig. <a href="#F4">4</a><I>B</I>,
<I>lower panel</I>). These results indicate that also
<I>in vitro</I><SUP> </SUP>PPCA</A> was able to promote the oligomerization of
neuraminidase.<SUP> </SUP>This process appeared to take place in two steps.
Initially, oligomers<SUP> </SUP>of ~600 kDa were formed that probably consisted
of six dimers<SUP> </SUP>that further multimerized in an ~1100-kDa form. We
conclude that<SUP> </SUP>the interaction between PPCA</A> and neuraminidase is
required for<SUP> </SUP>both the oligomerization and catalytic activity of
neuraminidase,<SUP> </SUP>and the two events cannot be separated.



<BR CLEAR=ALL><A NAME="F4"><!-- FIG 4 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/48/37657/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=175 HEIGHT=200 SRC="/content/vol275/issue48/images/small/bc4609180004.gif"></A><BR>

<STRONG>View larger version</STRONG> (43K):
<BR><NOBR><A HREF="/cgi/content/full/275/48/37657/F4">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/48/37657/F4"
onClick="startTarget('F4', 535, 640); this.href='/cgi/content-nw/full/275/48/37657/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. &nbsp;</STRONG>

<B><I>In vitro</I> multimerization and
catalytic activation of neuraminidase.</B> <I>A</I>, increasing
amounts of concanavalin A-purified HPP54 and MPP54 were added (0,&nbsp;1,&nbsp;3,&nbsp;and 5&nbsp;&#181;l) to purified dimeric mouse neuraminidase and subsequently
incubated at room temperature for 4&nbsp;h at either pH 5.0&nbsp;or 6.8.&nbsp;After incubation, the samples were assayed for neuraminidase activity
(nmol/h/ml). <I>B</I>, catalytically activated neuraminidase (5&nbsp;&#181;l of HPP54 added to dimeric mouse neuraminidase for optimal
activation) and mock-activated neuraminidase (bovine serum albumin
added instead of PPCA</A>) were resolved on a Sephacryl S300HR gel
filtration column at pH 5.0.&nbsp;Eluted fractions were separated on
SDS-polyacrylamide gels, blotted on polyvinylidene difluoride
membranes, and probed with anti-Neur antibodies. Molecular weights of
eluted proteins (native), and molecular weight standards are indicated
at the <I>top</I>. Molecular weights of proteins after SDS-PAGE
(denatured) are indicated at the <I>left</I>. Elution volume is
indicated at the <I>bottom</I>.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->







    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC3"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;DISCUSSION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>DISCUSSION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>Lysosomal neuraminidase shares significant homology with other
bacterial and mammalian members of the sialidase superfamily<SUP> </SUP>(<A HREF="#B2">2</A>). Most
neuraminidases are monomeric, but higher oligomeric<SUP> </SUP>states have been
reported (<A HREF="#B44">44</A>). The crystal structures of bacterial<SUP> </SUP>and viral
sialidases revealed that the fold topology of these<SUP> </SUP>enzymes is
identical and consists of a six-bladed <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-propeller<SUP> </SUP>around an axis
that passes through the active site (<A HREF="#B32">32-35</A>). It<SUP> </SUP>is likely that
lysosomal neuraminidase shares the same fold. Nevertheless,<SUP> </SUP>it is the
only member of the sialidase superfamily to require<SUP> </SUP>an accessory
protein (PPCA</A>) for its transport, catalytic activity,<SUP> </SUP>and stability in<SUP> </SUP>lysosomes.
    
    </P>

    
    <P>Little is known about the mechanism of complex assembly between
neuraminidase, PPCA</A>, and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase. We have used the<SUP> </SUP>baculovirus expression system to co-express neuraminidase in insect<SUP> </SUP>cells, with PPCA</A> and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase precursors, and the two separate<SUP> </SUP>PPCA</A> subunits (<A HREF="#B20">20</A>). BV-encoded PPCA</A> precursor and the two separate<SUP> </SUP>subunits were synthesized in the insect cells in large amounts<SUP> </SUP>and
transported from the endoplasmic reticulum to the Golgi compartment,<SUP> </SUP>but they were not segregated to the vacuole, which explains their<SUP> </SUP>lack
of maturation (<A HREF="#B20">20</A>). In mammalian cells we could not separate<SUP> </SUP>the effect
that PPCA</A> had on the transport of neuraminidase to<SUP> </SUP>lysosomes (<A HREF="#B18">18</A>) from
the actual activation event. Since PPCA</A><SUP> </SUP>and neuraminidase probably lack
the appropriate signals for vacuolar<SUP> </SUP>sorting in insect cells, we were
able to test the influence of<SUP> </SUP>PPCA</A> on the catalytic activation of
neuraminidase, independent<SUP> </SUP>from its intracellular<SUP> </SUP>transport.
    
    </P>

    
    <P>Many lysosomal hydrolases, after segregation to lysosomes, undergo
partial proteolytic processing, resulting in the removal<SUP> </SUP>of either
C-terminal or N-terminal fragments, leading to the mature,<SUP> </SUP>active forms
of the enzymes (<A HREF="#B36">36</A>). Recently, we reported the<SUP> </SUP>mechanisms of catalytic
activation of lysosomal <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase<SUP> </SUP>and PPCA</A>, showing that both
are two-subunit enzymes. The 85-kDa<SUP> </SUP><IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase precursor is
C-terminally processed by the cleavage<SUP> </SUP>of a 24-kDa domain, which
remains noncovalently associated to<SUP> </SUP>the 64-kDa N-terminal polypeptide
(<A HREF="#B37">37</A>). The one-chain PPCA</A> zymogen<SUP> </SUP>is processed by a trypsin-like
protease, removing an ~20-amino<SUP> </SUP>acid linker-peptide between the two
subunits. The two subunits<SUP> </SUP>are linked by disulfide bridges, resulting
in a 32/20-kDa two-chain<SUP> </SUP>active enzyme (<A HREF="#B20">20</A>). The crystal structure of
BV-expressed PPCA</A><SUP> </SUP>precursor indicated that the removal of the
linker-peptide triggers<SUP> </SUP>conformational changes in a subdomain of the
PPCA</A>, that in turn<SUP> </SUP>expose the catalytic pocket (<A HREF="#B21">21</A>). Unlike PPCA</A> and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase<SUP> </SUP>precursors, neuraminidase is catalytically activated
by a different<SUP> </SUP>mechanism that requires the interaction with PPCA</A>. A
pool of neuraminidase,<SUP> </SUP>PPCA</A>, and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, when co-expressed
in insect cells,<SUP> </SUP>assembled into a high molecular weight complex. The
exact stoichiometry<SUP> </SUP>of this multienzyme complex is unknown, but its
molecular mass<SUP> </SUP>in insect cells (1350&nbsp;kDa) is similar to the
1000-1300-kDa molecular<SUP> </SUP>mass of the multienzyme complex isolated from
human fibroblasts<SUP> </SUP>and various other mammalian tissues (<A HREF="#B6">6-9</A>, <A HREF="#B13">13</A>,
<A HREF="#B38">38-41</A>). Our <I>in<SUP> </SUP>vitro</I> studies indicate that the complex
probably contains 12&nbsp;neuraminidase<SUP> </SUP>dimers. The number of PPCA</A> and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase molecules in the<SUP> </SUP>complex remains uncertain. The
multimerization of neuraminidase<SUP> </SUP>occurs only at acidic pH, which
implies that in mammalian cells<SUP> </SUP>the high molecular weight complex is
assembled in<SUP> </SUP>lysosomes.
    
    </P>

    
    <P>We have shown earlier that in the absence of PPCA</A>, neuraminidase formed
crystals when overexpressed in COS-1 cells. However,<SUP> </SUP>co-expression of
neuraminidase with PPCA</A> prevented crystal formation<SUP> </SUP>and promoted its
transport to the lysosomes and catalytic activation<SUP> </SUP>(<A HREF="#B18">18</A>, <A HREF="#B20">20</A>).
Association with PPCA</A> appeared to mediate correct<SUP> </SUP>folding and
oligomerization of the enzyme, preventing aggregation<SUP> </SUP>of partially
folded or unfolded molecules. A similar mechanism<SUP> </SUP>has been described
for the coagulation proteins von Willebrand<SUP> </SUP>factor and factor VIII
(<A HREF="#B42">42</A>). Factor VIII needs to associate<SUP> </SUP>with von Willebrand factor for
correct folding and segregation<SUP> </SUP>into the secretory pathway. In von
Willebrand patients, who are<SUP> </SUP>deficient in von Willebrand factor, factor
VIII aggregates and<SUP> </SUP>is subsequently degraded. The dependence of a
molecule on the<SUP> </SUP>association with a partner may be an important
mechanism to regulate<SUP> </SUP>at the protein level its biological activity.
Especially for neuraminidase,<SUP> </SUP>this principle could hold true. Sialic
acid residues, as the terminal<SUP> </SUP>sugars on carbohydrate chains, are the
first targets for hydrolysis.<SUP> </SUP>Thus, it may not always be beneficial to
have catalytically active<SUP> </SUP>neuraminidase in the lysosomes. An
equilibrium between neuraminidase<SUP> </SUP>and PPCA</A> could maintain the required
level of neuraminidase activity.<SUP> </SUP>In turn, this could explain the
"instability" of neuraminidase<SUP> </SUP>during enzyme purifications, which
is caused by dissociation from<SUP> </SUP>the complex and/or detachment from PPCA</A>
(<A HREF="#B6">6-10</A>, <A HREF="#B12">12</A>). Given the<SUP> </SUP>biological integrity and functionality of
BV-expressed neuraminidase,<SUP> </SUP>including its association with PPCA</A> and
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase, this<SUP> </SUP>expression system can be of great value not
only for biochemical<SUP> </SUP>analysis but also for the crystallization and
three-dimensional<SUP> </SUP>structure determination of this enzyme and ultimately
of the multienzyme<SUP> </SUP>complex.
    
    


<BR><BR CLEAR=ALL>

</TXT>



<!-- Stray figures and tables -->


<!-- Acknowledgements -->

<A NAME="ack"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ACKNOWLEDGEMENT</FONT></TH>
</TR>
</TABLE>


<P>We thank Charlette Hill for editing this<SUP> </SUP>manuscript.
</P>

<!-- Notes -->


<!-- Footnotes -->

<A NAME="foo"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>



<P><A NAME="FN150"><SUP>*</SUP></A>
These studies were supported in part by National Institutes
of Health Grant RO1-GM60950, the Assisi foundation of Memphis,<SUP> </SUP>Cancer
Center Support Grant CA 21765,&nbsp;and the American Lebanese<SUP> </SUP>Syrian
Associated Charities of St. Jude Children's Research Hospital.The<SUP> </SUP>costs of publication of this
article were defrayed in part by<SUP> </SUP>the
payment of page charges. The article
must therefore be hereby<SUP> </SUP>marked
"<I>advertisement</I>" in
accordance with 18&nbsp;U.S.C. Section
1734<SUP>&nbsp;</SUP>solely to indicate this<SUP> </SUP>fact.

<P>
<P><A NAME="FN152"><SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP></A>
To whom correspondence should be addressed: St. Jude Children's
Research Hospital, Department of Genetics, 332&nbsp;N.&nbsp;Lauderdale,<SUP> </SUP>Memphis, TN 38105.&nbsp;Fax: 901-526-2907; E-mail: alessandra.
<A HREF="mailto:dazzo@stjude.org">dazzo@stjude.org</A>.

<P>


<P>
Published, JBC Papers in Press, September 11,&nbsp;2000,&nbsp;DOI 10.1074/jbc.M007380200

<P>

<A NAME="abb"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABBREVIATIONS</FONT></TH>
</TR>
</TABLE>

<P>The abbreviations used are: 

PPCA, protective
protein/cathepsin A;

BV, baculovirus;

PAGE, polyacrylamide gel
electrophoresis;

TEA, triethanolamine.

</P>


<!-- Appendices -->

<!-- Bibliography -->




<A NAME="References"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">DISCUSSION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>REFERENCES</FONT>
</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Pshezhetsky, A.,
Richard, C.,
Michaud, L.,
Igdoura, S.,
Wang, S.,
Elsliger, M.,
Qu, J.,
Leclerc, D.,
Gravel, R.,
Dallaire, L.,
 and Potier, M.



(1997)

<I>Nat. Genet.</I>
<B>15</B>,
316-320<!-- HIGHWIRE ID="275:48:37657:1" --><A HREF="/cgi/external_ref?access_num=9054950&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9054950&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Bonten, E.,
Spoel, A. v. d.,
Fornerod, M.,
Grosveld, G.,
 and d'Azzo, A.



(1996)

<I>Genes Dev.</I>
<B>10</B>,
3156-3169<!-- HIGHWIRE ID="275:48:37657:2" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=10/24/3156">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

Wenger, D. A.,
Tarby, T. J.,
 and Wharton, C.



(1978)

<I>Biochem. Cell Biol.</I>
<B>82</B>,
589-595<!-- HIGHWIRE ID="275:48:37657:3" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>

Andria, G.,
Strisciuglio, P.,
Pontarelli, G.,
Sly, W. S.,
 and Dodson, W. E.



(1981)

in 
<I>Sialidases and Sialidoses</I>


 (Durand, P.
, Tettamanti, G.

, and DiDonato, S., eds)
, pp. 379-395, Edizioni Ermes, Milan
    <!-- HIGHWIRE ID="275:48:37657:4" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

d'Azzo, A.,
Andria, G.,
Strisciuglio, P.,
 and Galjaard, H.



(1995)

in 
<I>The Metabolic and Molecular Bases of Inherited Disease</I>


 (Scriver, C.
, Beaudet, A.
, Sly, W.

, and Valle, D., eds), 7th Ed., Vol. 2
, pp. 2825-2838, McGraw-Hill Publishing Co., New York
    <!-- HIGHWIRE ID="275:48:37657:5" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

Pshezhetsky, A.,
 and Potier, M.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
28359-28365<!-- HIGHWIRE ID="275:48:37657:6" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/45/28359"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Verheijen, F.,
Brossmer, R.,
 and Galjaard, H.



(1982)

<I>Biochem. Cell Biol.</I>
<B>108</B>,
868-875<!-- HIGHWIRE ID="275:48:37657:7" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Verheijen, F. W.,
Palmeri, S.,
Hoogeveen, A. T.,
 and Galjaard, H.



(1985)

<I>Eur. J.&nbsp;Biochem.</I>
<B>149</B>,
315-321<!-- HIGHWIRE ID="275:48:37657:8" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ejbiochem&resid=149/2/315">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Yamamoto, Y.,
 and Nishimura, K.



(1987)

<I>J. Biochem.</I> (<I>Tokyo</I>)<I></I>
<B>19</B>,
435-442<!-- HIGHWIRE ID="275:48:37657:9" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Pshezhetsky, A. V.,
 and Potier, M.



(1994)

<I>Arch. Biochem. Biophys.</I>
<B>313</B>,
64-70<!-- HIGHWIRE ID="275:48:37657:10" --><A HREF="/cgi/external_ref?access_num=10.1006/abbi.1994.1359&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8053688&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8053688&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Hiraiwa, M.,
 and Kishimoto, Y.



(1996)

<I>Seikagaku</I>
<B>68</B>,
464-474<!-- HIGHWIRE ID="275:48:37657:11" --><A HREF="/cgi/external_ref?access_num=8741292&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8741292&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>

Hiraiwa, M.,
Saitoh, M.,
Arai, N.,
TShiraishi,
Odani, S.,
Uda, Y.,
Ono, T.,
 and O'Brien, J.



(1997)

<I>Biochim. Biophys. Acta</I>
<B>1341</B>,
189-199<!-- HIGHWIRE ID="275:48:37657:12" --><A HREF="/cgi/external_ref?access_num=9357958&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9357958&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Scheibe, R.,
Hein, K.,
 and Wenzel, K. W.



(1990)

<I>Biomed. Biochim. Acta</I>
<B>49</B>,
547-556<!-- HIGHWIRE ID="275:48:37657:13" --><A HREF="/cgi/external_ref?access_num=2126433&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2126433&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Hoogeveen, A. T.,
Verheijen, F. W.,
 and Galjaard, H.



(1983)

<I>J. Biol. Chem.</I>
<B>258</B>,
12143-12146<!-- HIGHWIRE ID="275:48:37657:14" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=258/20/12143"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

Hubbes, M.,
d'Agrosa, R. M.,
 and Callahan, J. W.



(1992)

<I>Biochem. J.</I>
<B>285</B>,
827-831<!-- HIGHWIRE ID="275:48:37657:15" --><A HREF="/cgi/external_ref?access_num=1497620&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1497620&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

d'Azzo, A.,
Hoogeveen, A.,
Reuser, A. J.,
Robinson, D.,
 and Galjaard, H.



(1982)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>79</B>,
4535-4539<!-- HIGHWIRE ID="275:48:37657:16" --><A HREF="/cgi/external_ref?access_num=6812049&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=6812049&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

van Diggelen, O. P.,
Hoogeveen, A. T.,
Smith, P. J.,
Reuser, A. J.,
 and Galjaard, H.



(1982)

<I>Biochim. Biophys. Acta</I>
<B>703</B>,
69-76<!-- HIGHWIRE ID="275:48:37657:17" --><A HREF="/cgi/external_ref?access_num=6803839&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=6803839&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

van der Spoel, A.,
Bonten, E.,
 and d'Azzo, A.



(1998)

<I>EMBO J.</I>
<B>17</B>,
1588-1597<!-- HIGHWIRE ID="275:48:37657:18" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=17/6/1588"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Vinogradova, M.,
Michaud, L.,
Mezentsev, A.,
Lukong, K.,
El-Alfy, M.,
Morales, C.,
Potier, M.,
 and Pshezhetsky, A.



(1998)

<I>Biochem. J.</I>
<B>330</B>,
641-650<!-- HIGHWIRE ID="275:48:37657:19" --><A HREF="/cgi/external_ref?access_num=9480870&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9480870&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Bonten, E. J.,
Galjart, N. J.,
Willemsen, R.,
Usmany, M.,
Vlak, J. M.,
 and d'Azzo, A.



(1995)

<I>J. Biol. Chem.</I>
<B>270</B>,
26441-26445<!-- HIGHWIRE ID="275:48:37657:20" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=270/44/26441"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

Rudenko, G.,
Bonten, E.,
d'Azzo, A.,
 and Hol, W. G.&nbsp;J.



(1995)

<I>Structure</I>
<B>3</B>,
1249-1259<!-- HIGHWIRE ID="275:48:37657:21" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nar&resid=3/5/1249">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

Luckow, V. A.,
 and Summers, M. D.



(1988)

<I>Virology</I>
<B>167</B>,
56-71<!-- HIGHWIRE ID="275:48:37657:22" --><A HREF="/cgi/external_ref?access_num=3142147&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=3142147&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B23">23.</a>
    <TD VALIGN=TOP>

Luckow, V. A.,
 and Summers, M. D.



(1988)

<I>Bio/Technology</I>
<B>6</B>,
47-55<!-- HIGHWIRE ID="275:48:37657:23" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B24">24.</a>
    <TD VALIGN=TOP>

Hink, W. F.



(1970)

<I>Nature</I>
<B>226</B>,
466-467<!-- HIGHWIRE ID="275:48:37657:24" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B25">25.</a>
    <TD VALIGN=TOP>

Morreau, H.,
Galjart, N. J.,
Gillemans, N.,
Willemsen, R.,
van der Horst, G. T.&nbsp;J.,
 and d'Azzo, A.



(1989)

<I>J. Biol. Chem.</I>
<B>264</B>,
20655-20663<!-- HIGHWIRE ID="275:48:37657:25" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=264/34/20655"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B26">26.</a>
    <TD VALIGN=TOP>

Galjart, N. J.,
Gillemans, N.,
Meijer, D.,
 and d'Azzo, A.



(1990)

<I>J. Biol. Chem.</I>
<B>265</B>,
4678-4684<!-- HIGHWIRE ID="275:48:37657:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=265/8/4678"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B27">27.</a>
    <TD VALIGN=TOP>Summers, M.&nbsp;D., and Smith, G.&nbsp;E.&nbsp;(1987) <I>Tex. Agric.
Exp. Stn. Bull.</I> <B>1555</B>
    <!-- HIGHWIRE ID="275:48:37657:27" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B28">28.</a>
    <TD VALIGN=TOP>

Galjart, N. J.,
Morreau, H.,
Willemsen, R.,
Gillemans, N.,
Bonten, E. J.,
 and d'Azzo, A.



(1991)

<I>J. Biol. Chem.</I>
<B>266</B>,
14754-14762<!-- HIGHWIRE ID="275:48:37657:28" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=266/22/14754"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B29">29.</a>
    <TD VALIGN=TOP>

Proia, R. L.,
d'Azzo, A.,
 and Neufeld, E. F.



(1984)

<I>J. Biol. Chem.</I>
<B>259</B>,
3350-3354<!-- HIGHWIRE ID="275:48:37657:29" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=259/5/3350"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B30">30.</a>
    <TD VALIGN=TOP>

Zhou, X. Y.,
Morreau, H.,
Rottier, R.,
Davis, D.,
Bonten, E.,
Gillemans, N.,
Wenger, D.,
Grosveld, F. G.,
Doherty, P.,
Suzuki, K.,
Grosveld, G. C.,
 and d'Azzo, A.



(1995)

<I>Genes Dev.</I>
<B>9</B>,
2623-2634<!-- HIGHWIRE ID="275:48:37657:30" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=9/21/2623">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B31">31.</a>
    <TD VALIGN=TOP>

Rottier, R.,
Bonten, E.,
 and d'Azzo, A.



(1998)

<I>Hum. Mol. Genet.</I>
<B>7</B>,
313-321<!-- HIGHWIRE ID="275:48:37657:31" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=hmg&resid=7/2/313"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B32">32.</a>
    <TD VALIGN=TOP>

Crennell, S. J.,
Garman, E. F.,
Laver, W. G.,
Vimr, E. R.,
 and Taylor, G. L.



(1993)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>90</B>,
9852-9856<!-- HIGHWIRE ID="275:48:37657:32" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=90/21/9852">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B33">33.</a>
    <TD VALIGN=TOP>

Crennell, S.,
Garman, E.,
Laver, G.,
Vimr, E.,
 and Taylor, G.



(1994)

<I>Structure</I>
<B>2</B>,
535-544<!-- HIGHWIRE ID="275:48:37657:33" --><A HREF="/cgi/external_ref?access_num=7922030&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7922030&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B34">34.</a>
    <TD VALIGN=TOP>

Crennell, S.,
Garman, E.,
Philippon, C.,
Vasella, A.,
Laver, W.,
Vimr, E.,
 and Taylor, G.



(1996)

<I>J. Mol. Biol.</I>
<B>259</B>,
264-280<!-- HIGHWIRE ID="275:48:37657:34" --><A HREF="/cgi/external_ref?access_num=10.1006/jmbi.1996.0318&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8656428&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8656428&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B35">35.</a>
    <TD VALIGN=TOP>

Gaskell, A.,
Crennell, S.,
 and Taylor, G.



(1995)

<I>Structure</I>
<B>3</B>,
1197-1205<!-- HIGHWIRE ID="275:48:37657:35" --><A HREF="/cgi/external_ref?access_num=8591030&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8591030&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B36">36.</a>
    <TD VALIGN=TOP>

Braulke, T.



(1996)

in 
<I>Origin of Lysosomal Proteins</I>


 (Mason, L. A., ed), Vol. 27
, pp. 15-49, Plenum Press, New York
    <!-- HIGHWIRE ID="275:48:37657:36" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B37">37.</a>
    <TD VALIGN=TOP>

van der Spoel, A. C.,
Bonten, E. J.,
 and d'Azzo, A.



(2000)

<I>J. Biol. Chem.</I>
<B>275</B>,
10035-10040<!-- HIGHWIRE ID="275:48:37657:37" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/14/10035"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B38">38.</a>
    <TD VALIGN=TOP>

Verheijen, F. W.,
Palmeri, S.,
 and Galjaard, H.



(1987)

<I>Eur. J.&nbsp;Biochem.</I>
<B>162</B>,
63-67<!-- HIGHWIRE ID="275:48:37657:38" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ejbiochem&resid=162/1/63">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B39">39.</a>
    <TD VALIGN=TOP>

van der Horst, G.,
Galjart, N. J.,
d'Azzo, A.,
Galjaard, H.,
 and Verheijen, F. W.



(1989)

<I>J. Biol. Chem.</I>
<B>264</B>,
1317-1322<!-- HIGHWIRE ID="275:48:37657:39" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=264/2/1317"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B40">40.</a>
    <TD VALIGN=TOP>

Potier, M.,
Michaud, L.,
Tranchemontagne, J.,
 and Thauvette, L.



(1990)

<I>Biochem. J.</I>
<B>267</B>,
197-202<!-- HIGHWIRE ID="275:48:37657:40" --><A HREF="/cgi/external_ref?access_num=2109603&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2109603&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B41">41.</a>
    <TD VALIGN=TOP>

Hiraiwa, M.,
Uda, Y.,
Tsuji, S.,
Miyatake, T.,
Martin, B. M.,
Tayama, M.,
O'Brien, J. S.,
 and Kishimoto, Y.



(1991)

<I>Biochem. Cell Biol.</I>
<B>177</B>,
1211-1216<!-- HIGHWIRE ID="275:48:37657:41" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B42">42.</a>
    <TD VALIGN=TOP>

Kaufman, R. J.



(1999)

<I>Biochim. Biophys. Acta</I>
<B>1423</B>,
13-27<!-- HIGHWIRE ID="275:48:37657:42" --><A HREF="/cgi/external_ref?access_num=10.1016/S0304-419X(98)00029-8&link_type=DOI">[CrossRef]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B43">43.</a>
    <TD VALIGN=TOP>

Galjaard, H.



(1980)


<I>Genetic Metabolic Diseases: Early Signs and Prenatal Analysis</I>

, p. 817, Elsevier, New York
    <!-- HIGHWIRE ID="275:48:37657:43" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B44">44.</a>
    <TD VALIGN=TOP>

Taylor, G.



(1996)

<I>Curr. Opin. Struct. Biol.</I>
<B>6</B>,
830-837<!-- HIGHWIRE ID="275:48:37657:44" --><A HREF="/cgi/external_ref?access_num=10.1016/S0959-440X(96)80014-5&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8994884&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8994884&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>

</TABLE>



<P><HR>
<FONT SIZE=-1><A HREF="/misc/terms.shtml"><B>Copyright &#169; 2000 by The American Society for Biochemistry and Molecular Biology, Inc.</B></A></FONT>




<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	



 




<BR CLEAR=ALL>




<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://hmg.oupjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://hmg.oupjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://hmg.oupjournals.org"><IMG ALT="Hum Mol Genet" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/hmg.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	N. de Geest, E. Bonten, L. Mann, J. de Sousa-Hitzler, C. Hahn, and A. d'Azzo<BR>
	<STRONG>Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice</STRONG><BR>
	
		
			Hum. Mol. Genet.,
		
	
        
        June&nbsp;1,&nbsp;2002;
	11(12):
	1455 - 1464.
<BR>
<A HREF="http://hmg.oupjournals.org/cgi/content/abstract/11/12/1455">[Abstract]</A>

<A HREF="http://hmg.oupjournals.org/cgi/content/full/11/12/1455">[Full Text]</A>
<A HREF="http://hmg.oupjournals.org/cgi/reprint/11/12/1455">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>










<BR CLEAR=ALL>
<BR CLEAR=ALL>


	
	 
		  
			                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/48/37657">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/48/37657">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/48/37657">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/48/37657&title=Lysosomal+Neuraminidase.+CATALYTIC+ACTIVATION+IN+INSECT+CELLS+IS+CONTROLLED+BY+THE+PROTECTIVE+PROTEIN%2FCATHEPSIN+A">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M007380200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10982818&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10982818&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Bonten+EJ&link_type=AUTHORSEARCH">Bonten, E. J.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=d%27Azzo+A&link_type=AUTHORSEARCH">d'Azzo, A.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/48/37657&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F48%2F37657"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/48/37657">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/48/37657<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M007380200v1">M007380200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


					
	

<BR CLEAR=ALL>

        
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue48/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
        <TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
        <TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 2000 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
